Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
We are testing the additional effects of a tablet that is already proven to benefit kidney function.
Near-infrared fluorescence light can detect the atherosclerotic plaques that lead to heart attack and stroke.
Imaging athletes’ hearts during exercise, not at rest.
Biomarkers that highlight toxic fats in the liver.
Benefits for type 2 diabetes of interrupting prolonged sitting.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more